Sartorius strengthens collaboration with LFB Biomanufacturing

Sartorius and LFB Biomanufacturing have announced an expansion of their collaboration with the aim of offering biop...

June 23, 2026 | Tuesday | News
Lys Therapeutics raises over €25M to advance neurovascular antibody

Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...

June 23, 2026 | Tuesday | News
Beyond Instruments: Building the Connected, Sustainable Laboratory of Tomorrow

As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...

June 18, 2026 | Thursday | Opinion
WuXi Biologics Suzhou Testing Centre Secures Fourth EMA GMP Certification

WuXi Biologics’ Suzhou Biosafety Testing Center has passed a European Medicines Agency Good Manufacturing Practice...

June 18, 2026 | Thursday | News
Japan's Eisai invests £48 M to build cold-chain capability in UK

Japanese pharma firm Eisai Co. has announced a strategic investment supported by the UK Government under the Life Scienc...

June 17, 2026 | Wednesday | News
Lundbeck Reports Phase II Data for Asedebart in Cushing’s Disease

Lundbeck has presented preliminary Phase II Part A data for asedebart, an investigational anti-adrenocorticotropic hormo...

June 15, 2026 | Monday | News
CARsgen Presents Allogeneic CAR-T Data for Blood Cancers at EHA 2026

CARsgen Therapeutics has presented new clinical data for two allogeneic CAR-T cell therapy candidates, CT0596 and CT1190...

June 15, 2026 | Monday | News
Why Donor Supply Chains May Decide the Future of Cell Therapy Commercialisation

As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...

June 15, 2026 | Monday | News
MaaT Pharma Reports Phase 3 Data for Microbiome Therapy in Acute GvHD

MaaT Pharma has presented final Phase 3 data from the ARES pivotal trial evaluating MaaT013 in acute graft-versus-host d...

June 11, 2026 | Thursday | News
Sanofi Secures EU Approval for Subcutaneous Sarclisa in Multiple Myeloma

Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...

June 10, 2026 | Wednesday | News
Argo Biopharma to Present Updated Phase II Data for siRNA HAE Therapy at EAACI 2026

Argo Biopharma will present updated Phase II results for BW-20805, its investigational siRNA therapy for hereditary angi...

June 9, 2026 | Tuesday | News
VERTANICAL Secures First European Marketing Authorisation for Exilby in Chronic Low Back Pain

VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...

June 9, 2026 | Tuesday | News
Hansa Biopharma Reports Positive European Post-Authorisation Data for Idefirix

Hansa Biopharma has reported positive topline results from a European post-authorisation efficacy study of Idefirix in h...

June 8, 2026 | Monday | News
Amgen Receives EC Approval for IMDYLLTRA in Extensive-Stage Small Cell Lung Cancer

Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...

June 5, 2026 | Friday | News
AbbVie Secures EC Approval for AQUIPTA as Acute Migraine Treatment

AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...

June 5, 2026 | Friday | News
Henlius and Organon Secure EC Approval for First Pertuzumab Biosimilar in Europe

Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...

June 4, 2026 | Thursday | News
Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6

Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...

June 4, 2026 | Thursday | News
Enbiosis Biotechnology unveils proprietary nutraceutical formulation engine Enbiosis 2.0

Artificial intelligence (AI) has reshaped drug discovery, diagnostics, and genomics. The nutraceutical sector has been s...

May 27, 2026 | Wednesday | News
Hong Kong's Cornerstone Robotics receives European Union CE mark

Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, China, has announced tha...

May 25, 2026 | Monday | News
AUTOMA+ 2026: Practical Digitalisation for Industrial Pharma

Most pharma digitalisation projects never leave the pilot stage. AUTOMA+ 2026 is built for the ones that do. Fragmented ...

May 18, 2026 | Monday | News
Vetter starts construction of new facility in Germany for production of injectable drugs

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has announced the start of constructi...

May 14, 2026 | Thursday | News
Thermo Fisher sells microbiology biz to Astorg for $1.075 B

US-based Thermo Fisher Scientific Inc. has signed a definitive agreement to sell its microbiology business to Astorg, a ...

April 28, 2026 | Tuesday | News
CEPI and Pasteur Network partner to advance regional vaccine R&D

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Pasteur Network (PN), in Paris, have signed ...

April 24, 2026 | Friday | News
Merck Launches Bio Based Solvent Portfolio For High Performance Liquid Chromatography

Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography   Solvents made fro...

April 23, 2026 | Thursday | News
Freudenberg Medical launches ISO Class 5 controlled cleanroom for sterile single-use assemblies

Germany-based Freudenberg Medical, a global contract design and manufacturing partner to the medical device and bio...

April 20, 2026 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls